You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Sclerosis, Chronic Progressive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Chronic Progressive Trial in Cleveland (Cionic

Recruiting
  • Multiple Sclerosis
  • +2 more
  • Cionic Neural Sleeve NS-100
  • Actigraph accelerometer
  • Cleveland, Ohio
    Cleveland State University
Jul 25, 2023

Mitochondrial Dysfunction in Primary Progressive Multiple

Recruiting
  • Multiple Sclerosis
    • Milan, MI, Italy
    • +1 more
    Aug 29, 2023

    Multiple Sclerosis, Progressive Multiple Sclerosis Trial in Bergen (Nicotinamid riboside, Placebo)

    Not yet recruiting
    • Multiple Sclerosis
    • Progressive Multiple Sclerosis
    • Nicotinamid riboside
    • Placebo
    • Bergen, Norway
      Haukeland University Hospital
    Feb 22, 2023

    Multiple Sclerosis Trial (Frexalimab, Placebo, MRI contrast-enhancing agents)

    Not yet recruiting
    • Multiple Sclerosis
    • (no location specified)
    Nov 15, 2023

    Mayzent Onboarding of Secondary Progressive Multiple Sclerosis

    Completed
    • Secondary Progressive Multiple Sclerosis
      • Camperdown, New South Wales, Australia
      • +1 more
      Apr 19, 2023

      Ocrelizumab on Choroid Plexus Changes in Patients With PPMS

      Not yet recruiting
      • Primary Progressive Multiple Sclerosis
      • Ocrelizumab
      • Buffalo, New York
        Buffalo Neuroimaging Analysis Center
      Jul 26, 2023

      Multiple Sclerosis, Chronic Progressive, High-Intensity Interval Training, Motor Symptoms Trial in Valens (HIIT, MCT)

      Recruiting
      • Multiple Sclerosis, Chronic Progressive
      • +2 more
      • HIIT
      • MCT
      • Valens, Sankt Gallen, Switzerland
        Klinik Valens, Valens rehabilitation clinic
      Oct 12, 2022

      Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • KYV-101 anti-CD19 CAR-T cell therapy
      • Standard lymphodepletion regimen
      • Palo Alto, California
        Stanford Multiple Sclerosis Center
      Nov 13, 2023

      Multiple Sclerosis (MS) Patients

      Not yet recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
        • (no location specified)
        Dec 15, 2022

        Progressive Multiple Sclerosis Trial in Ghent (Bytelfies kit - sensor dot)

        Recruiting
        • Progressive Multiple Sclerosis
        • Bytelfies kit - sensor dot
        • Ghent, Oost-Vlaanderen, Belgium
          University Hospital Ghent
        Jan 5, 2023

        Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

        Not yet recruiting
        • Multiple Sclerosis (MS)
        • +6 more
        • Clemastine Fumarate
        • Placebo
        • San Francisco, California
          Sandler Neurosciences Building, Neurological Clinical Research U
        Jan 23, 2023

        Progressive Multiple Sclerosis Trial (Transcranial static magnetic field stimulation (tSMS), Sham Transcranial static magnetic

        Not yet recruiting
        • Progressive Multiple Sclerosis
        • Transcranial static magnetic field stimulation (tSMS)
        • Sham Transcranial static magnetic field stimulation (tSMS)
        • (no location specified)
        Mar 30, 2023

        Progressive Multiple Sclerosis Trial in Genova, Roma (Osmotin)

        Recruiting
        • Progressive Multiple Sclerosis
        • Osmotin
        • Genova, Italy
        • +1 more
        Jun 30, 2023

        Microglia in the Pathogenesis of Progressive Multiple Sclerosis

        Active, not recruiting
        • Multiple Sclerosis
          • Turku, Finland Proper, Finland
            Turku PET Centre
          Oct 12, 2022

          Ocrelizumab on Cortical Lesion Accumulation in PPMS

          Not yet recruiting
          • Primary Progressive Multiple Sclerosis
          • Ocrelizumab
          • (no location specified)
          Aug 2, 2023

          Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

          Recruiting
          • Multiple Sclerosis, Secondary Progressive
          • Multiple Sclerosis
          • Cladribine Subcutaneous Injection
          • 0.9% Chloride Injection Sodium
          • Warsaw, Mazowieckie, Poland
            Institute of Psychiatry and Neurology
          Jul 26, 2023

          Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Tokyo (OCH-NCNP1, Placebo)

          Active, not recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • Multiple Sclerosis, Secondary Progressive
          • Tokyo, Japan
            National Center of Neurology and Psychiatry
          Sep 28, 2022

          Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

          Not yet recruiting
          • Multiple Sclerosis
          • +2 more
          • Metformin Hydrochloride 850 mg Oral Tablet
          • Placebo
          • Brugge, Belgium
          • +4 more
          May 30, 2023

          Multiple Sclerosis Trial (Siponimod)

          Available
          • Multiple Sclerosis
          • (no location specified)
          Sep 13, 2022

          Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

          Recruiting
          • Secondary-progressive Multiple Sclerosis
          • Buffalo, New York
            University at Buffalo, Buffalo General Hospital
          Oct 10, 2022

          Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

          Completed
          • Multiple Sclerosis, Relapsing-Remitting
          • +2 more
          • 18F-DPA-714 and 18F-FDG
          • Paris, France
          • +1 more
          Sep 14, 2022

          Multiple Sclerosis, Chronic Progressive Trial in United States (NurOwn (MSC-NTF cells))

          Completed
          Has Results
          • Multiple Sclerosis, Chronic Progressive
          • NurOwn (MSC-NTF cells)
          • Los Angeles, California
          • +3 more
          Oct 20, 2022

          Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Birmingham, Saint Louis (Glycemic

          Not yet recruiting
          • Relapsing Remitting Multiple Sclerosis
          • Secondary Progressive Multiple Sclerosis
          • Glycemic load
          • +2 more
          • Birmingham, Alabama
          • +1 more
          Jan 4, 2023

          Progressive Multiple Sclerosis Trial in Regina (Exercise Group 1, Exercise Group 2, Exercise Group 3)

          Recruiting
          • Progressive Multiple Sclerosis
          • Exercise Group 1
          • +2 more
          • Regina, Saskatchewan, Canada
            University of Regina
          Aug 8, 2022

          Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Training groupe, PNF,

          Completed
          • Multiple Sclerosis, Chronic Progressive
          • Multiple Sclerosis, Primary Progressive
          • Training groupe
          • +3 more
          • Kaposvár, Somogy, Hungary
            Somogy Megyei Kaposi Mór Oktató Kórház
          Mar 24, 2022